SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-038791
Filing Date
2023-10-31
Accepted
2023-10-31 08:05:23
Documents
14
Period of Report
2023-10-31
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37974
2 ex99-1.htm EX-99.1 16710
3 ex99-1_001.jpg GRAPHIC 2972
  Complete submission text file 0001493152-23-038791.txt   238547

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE envb-20231031.xsd EX-101.SCH 3012
5 XBRL LABEL FILE envb-20231031_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE envb-20231031_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3443
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 231362338
SIC: 2834 Pharmaceutical Preparations